Company profile: Enveda Biosciences
1.1 - Company Overview
Company description
- Provider of a drug discovery platform using machine learning, metabolomics, robotics, and the MS2Mol AI to index nature’s chemical space and predict structures from mass spectrometry, rapidly identifying small molecules; harnesses nature’s chemical diversity to deliver new medicines for complex diseases, novel modalities (protein degradation, stabilization, covalent inhibition), novel targets, and a pipeline in pain, dermatology, immunology, inflammation, and neuroinflammation.
Products and services
- Drug Discovery Platform: Architects a robotics-integrated system leveraging machine learning and metabolomics to index nature’s chemical space, enabling rapid identification and study of bioactive small molecules
- MS2Mol: Delivers an AI-driven algorithm that predicts chemical properties and structures directly from mass spectrometry data to power and accelerate the platform’s natural-product drug discovery
- New Modalities: Produces mechanism-specific chemistries that enable protein degradation, stabilization, and covalent inhibition, introducing new ways to manipulate disease-relevant proteins for therapeutic intervention
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enveda Biosciences
Integromics
HQ: Spain
Website
- Description: Provider of bioinformatics software solutions for life sciences, focused on data management and advanced validated analysis in genomics and proteomics, enabling scientists to organize data, perform analyses, and discover new biomedical knowledge; operating in the global life sciences market with a network of collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integromics company profile →
EmpiraMed
HQ: United States
Website
- Description: Provider of registry patient-engagement software to generate real-world evidence for the life science industry, delivering a decentralized clinical study solution with automated study execution, novel patient recruitment, and mobile device independence. Products include PRO, PMR, and MED Portals, Decentralized Study Platform, Patient Incentive System, and Data Verification Model.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EmpiraMed company profile →
InCrowd
HQ: United States
Website
- Description: Provider of a market research platform for life sciences companies to obtain real-time feedback from healthcare professionals. Offerings include MicroSurvey for short, real-time surveys; MicroTracker and Essentials for wave-over-wave tracking; InCrowd Interview for automated qualitative research; and Access/Access+ to a global panel of healthcare professionals and patients with survey support and optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InCrowd company profile →
Labvanced
HQ: Germany
Website
- Description: Provider of a software solution that combines online study design, data recording, automated analysis, and data visualizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labvanced company profile →
Ampersand Biomedicines
HQ: United States
Website
- Description: Provider of programmable medicines and platforms that precisely target disease sites, including AND-Body Therapeutics for disease-specific precision and modification; the AND-Platform, a computational and experimental system enabled by a proprietary Address Map; the Opportunity Atlas for identifying localized targets; and enhanced biologic generation via AbCheck’s antibody discovery technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampersand Biomedicines company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enveda Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enveda Biosciences
2.2 - Growth funds investing in similar companies to Enveda Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enveda Biosciences
4.2 - Public trading comparable groups for Enveda Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →